Cardiff Oncology, Inc. - stock earnings
CRDF Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -10.2 million USD | 156000 USD |
| 2023Q3 | -9.7 million USD | 141000 USD |
| 2023Q2 | -11.2 million USD | 108000 USD |
| 2023Q1 | -10.4 million USD | 83000 USD |
| 2022Q4 | -8.0 million USD | 128000 USD |
| 2022Q3 | -8.1 million USD | 93000 USD |
| 2022Q2 | -10.2 million USD | 91000 USD |
| 2022Q1 | -10.9 million USD | 74000 USD |
| 2021Q4 | -9.4 million USD | 133000 USD |
| 2021Q3 | -6.9 million USD | 86000 USD |
| 2021Q2 | -6.8 million USD | 68000 USD |
| 2021Q1 | -5.2 million USD | 72000 USD |
| 2020Q4 | -6.6 million USD | 119255 USD |
| 2020Q3 | -4.5 million USD | 136401 USD |
| 2020Q2 | -4.1 million USD | 42633 USD |
| 2020Q1 | -4.1 million USD | 67704 USD |
| 2019Q4 | -4.2 million USD | 93000 USD |
| 2019Q3 | -4.1 million USD | 51687 USD |
| 2019Q2 | -4.1 million USD | 138000 USD |
| 2019Q1 | -3.9 million USD | 162000 USD |
| 2018Q4 | -4.2 million USD | 78000 USD |
| 2018Q3 | -3.8 million USD | 88361 USD |
| 2018Q2 | -3.7 million USD | 111813 USD |
| 2018Q1 | -4.8 million USD | 100136 USD |
| 2017Q4 | -2.6 million USD | 185000 USD |
| 2017Q3 | -4.3 million USD | 123329 USD |
| 2017Q2 | -8.0 million USD | 102011 USD |
| 2017Q1 | -10.0 million USD | 95038 USD |
| 2016Q4 | -8.5 million USD | 68000 USD |
| 2016Q3 | -10.2 million USD | 89114 USD |
| 2016Q2 | -10.2 million USD | 103400 USD |
| 2016Q1 | -10.3 million USD | 120486 USD |
| 2015Q4 | -7.4 million USD | 79000 USD |
| 2015Q3 | -2.7 million USD | 57327 USD |
| 2015Q2 | -10.2 million USD | 50000 USD |
| 2015Q1 | -7.2 million USD | 126970 USD |
| 2014Q4 | -4.7 million USD | 56000 USD |
| 2014Q3 | -5.4 million USD | 57199 USD |
| 2014Q2 | -1.1 million USD | 55628 USD |
| 2014Q1 | -3.2 million USD | 110953 USD |
| 2013Q4 | -1.0 million USD | 47367 USD |
| 2013Q3 | -4.4 million USD | 43756 USD |
| 2013Q2 | -5.3 million USD | 49000 USD |
| 2013Q1 | -6.3 million USD | 163000 USD |
| 2012Q4 | -6.3 million USD | 163251 USD |
| 2012Q3 | -650225 USD | 211500 USD |
| 2012Q2 | -3.4 million USD | 41500 USD |
| 2012Q1 | -1.2 million USD | 34153 USD |
| 2011Q4 | -1.2 million USD | 33750 USD |
| 2011Q3 | 9269 USD | 55000 USD |
| 2011Q2 | -449159 USD | 79863 USD |
| 2011Q1 | -551987 USD | 89082 USD |
| 2010Q4 | -980000 USD | 210000 USD |
| 2010Q3 | -3.6 million USD | 30000 USD |
| 2010Q2 | -520000 USD | 20000 USD |
| 2010Q1 | -380000 USD | ? USD |
| 2006Q3 | -1.6 million USD | ? USD |
| 2006Q2 | -1.7 million USD | ? USD |
| 2006Q1 | -1.9 million USD | ? USD |
| 2005Q3 | -996061 USD | ? USD |
| 2005Q2 | -4.6 million USD | ? USD |
| 2003Q3 | -862 USD | ? USD |
| 2003Q2 | -1374 USD | ? USD |
| 2003Q1 | -58 USD | ? USD |
CRDF Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -41.5 million USD | 488000 USD |
| 2022 | -37.5 million USD | 386000 USD |
| 2021 | -27.7 million USD | 359000 USD |
| 2020 | -19.3 million USD | 365993 USD |
| 2019 | -16.2 million USD | 245000 USD |
| 2018 | -16.5 million USD | 378000 USD |
| 2017 | -24.9 million USD | 505000 USD |
| 2016 | -39.2 million USD | 381000 USD |
| 2015 | -27.5 million USD | 313000 USD |
| 2014 | -14.3 million USD | 280000 USD |
| 2013 | -11.8 million USD | 259246 USD |
| 2012 | -11.6 million USD | 450000 USD |
| 2011 | -2.2 million USD | 257696 USD |
| 2010 | -5.4 million USD | 265665 USD |
| 2009 | -2.5 million USD | 650000 USD |
| 2005 | -7.8 million USD | ? USD |
| 2004 | -5.4 million USD | ? USD |
CRDF
Price: $4.07
52 week price:
Earnings Per Share: -0.93 USD
P/E Ratio: -1.97
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 531000
Market Capitalization: 252.9 million